No black box warning on record for Sulfasalazine

As of the latest FDA labeling reviewed, Sulfasalazine (SULFASALAZINE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Sulfasalazine medicine page for the complete safety profile.

Other warnings & precautions

WARNINGS Hepatic, Renal, and Hematologic Toxicity or Other Conditions Only after critical appraisal should Sulfasalazine Tablets be given to patients with hepatic or renal damage or blood dyscrasias. Deaths associated with the administration of sulfasalazine have been reported from hypersensitivity reactions, agranulocytosis, aplastic anemia, other blood dyscrasias, renal and liver damage, irrever

No black box warning on record for Sulfasalazine

Other warnings & precautions

WARNINGS Hepatic, Renal, and Hematologic Toxicity or Other Conditions Only after critical appraisal should Sulfasalazine Tablets be given to patients with hepatic or renal damage or blood dyscrasias. Deaths associated with the administration of sulfasalazine have been reported from hypersensitivity reactions, agranulocytosis, aplastic anemia, other blood dyscrasias, renal and liver damage, irrever

Sulfasalazine Black Box Warning

No black box warning on record for Sulfasalazine

Other warnings & precautions

Sulfasalazine Black Box Warning

No black box warning on record for Sulfasalazine

Other warnings & precautions